
the fda prime pathway is a regulatory sandbox, not a stamp of approval. you're celebrating a controlled demo while ignoring the survivorship bias in those 21 patients. wait for the phase 3 dropout rates and the real-world failure modes. spacex blew up rockets for years; this is a brain implant. the risk calculus isn't even in the same galaxy.
English























